1Material and supplier control
The segregation, rotation of stock, and/or the transportation of raw materials, packaging materials, intermediates, bulk drugs, and/or finished products was inadequate.
Inspection Record
Mid East Canadian Pharmaceutical Inc — Health Canada Inspection Findings
View the regulator's official source The source document is always the basis for judgement.
Findings
2Stability and storage
The temperature and/or humidity control was inadequate. The evidence used to demonstrate the transportation and/or storage conditions of each lot or batch of the drug was inadequate.
3Other quality system
The handling of standard operating procedures for good manufacturing practices was inadequate.
4Other quality system
The controls were inadequate for creating, modifying, reviewing, storing, and/or retrieving records.
5Laboratory and QC controls
The education, experience, and/or oversight of the individual in charge of the quality control department was inadequate.
About this record
Extracted automatically from the document of the Health Canada inspection on 2023-10-16. The source is available at the link above.
This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.
Translation and classification are automated and may differ in nuance from the source.
